Moleculin Biotech, Inc. to Present at the Oppenheimer 29th Annual Healthcare Conference and the 31st Annual ROTH Conference Mar 18, 2019
Moleculin Announces Outlicensing Deal To Accelerate Preclinical and Clinical Development Feb 20, 2019
Moleculin Announces Dr. James L. Abbruzzese, Chief of Medical Oncology Division at Duke University, Joins Science Advisory Board Jan 17, 2019
